Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioharvest Sciences Inc BHST


Primary Symbol: C.BHSC

Consumer Defensive Household & Personal Products Biotechnology
BioHarvest Sciences Inc. is a Canada-based biotechnology company. The Company offers Botanical Synthesis, its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The Company is leveraging its Botanical Synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business... see more

CSE:BHSC - Post Discussion

Bioharvest Sciences Inc > Cronos Group and Ginkgo Bioworks Announce Milestone
View:
Post by lscfa on Aug 23, 2021 1:05pm

Cronos Group and Ginkgo Bioworks Announce Milestone

By achieving commercial scale production of CBG, the companies are on track to enable access to rare cannabis molecules

 

https://www.globenewswire.com/news-release/2021/08/23/2284750/0/en/Cronos-Group-and-Ginkgo-Bioworks-Announce-Achievement-of-Equity-Milestone-in-Partnership-to-Produce-Cultured-Cannabinoids.html

Comment by 0checker on Sep 04, 2021 6:22am
In Ginko TOO, btw.
Bioharvest Sciences Inc